BOJI CRO(SZ:300404) Xin Lang Cai Jing·2025-10-29 02:14Core Viewpoint - Boji Pharmaceutical (300404.SZ) reported its Q3 2025 results, highlighting a decrease in institutional ownership and changes in public fund holdings [1] Institutional Investors - As of October 28, 2025, four institutional investors disclosed holdings in Boji Pharmaceutical, totaling 10.34 million shares, which represents 2.68% of the company's total equity [1] - The institutional ownership decreased by 1.39 percentage points compared to the previous quarter [1] Public Funds - One public fund, Dongcai Yuanjian Growth Mixed Initiation A, increased its holdings slightly in the current period [1] - A total of 28 public funds that were previously disclosed did not report their holdings this quarter, including notable funds such as Nuoan Pioneer Mixed A and Nuoan Preferred Return Mixed A [1] Foreign Investment - The foreign investment landscape saw the non-disclosure of BARCLAYS BANK PLC in the current period compared to the previous quarter [1]